What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?

What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?

What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Dan Atar, MD

Dan Atar, MD

Head of Research Oslo University Hospital Ulleval Professors of Cardiology University of Oslo Oslo, Norway Visiting Associate Professorship Johns Hopkins University Baltimore, Maryland